PT350 – Jim Gilligan – Psilocybin and Accessing the "Off" Switch For Nociplastic Pain
Podcast: Psychedelics TodayPublished On: Fri Aug 26 2022
Description: In this episode, David interviews Jim Gilligan: Interim CEO and Chief Scientific Officer of Tryp Therapeutics, a biotech company researching psychedelics for the treatment of eating disorders and nociplastic pain. www.psychedelicstoday.com
The note was deleted
The note was saved
Your message was sent